HOUSTON, June 05, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc. (NASDAQ:BPTH) (“Bio-Path” or the “Company”), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a
Related Keywords
United States , Houston , Texas , Doug Morris , Hc Wainwright Co , Nasdaq , Exchange Commission , Path Holdings Inc , Stern Investor Relations Inc , Path Holdings , Securities Act , Bio Path Holdings , Annual Report , Investor Relations ,
comparemela.com © 2020. All Rights Reserved.